Literature DB >> 21800157

Abdominal bloating and distension: what is the role of the microbiota.

B Issa1, N A Wafaei, P J Whorwell.   

Abstract

Most patients with irritable bowel syndrome complain of a sensation of an increase in pressure within their abdomen during the course of the day which is called bloating and, in approximately half of these individuals, this symptom is accompanied by an actual increase in abdominal girth, which is referred to as distension. The pathophysiology of these two phenomena is somewhat different and it is now recognised that a whole variety of overlapping mechanisms are involved. Some of these are potentially amenable to treatment by modification of the bacterial flora of the gut and this article reviews the evidence for this.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21800157     DOI: 10.1007/s10620-011-1834-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  48 in total

1.  Irritable bowel syndrome: shifting the focus toward the gut microbiota.

Authors:  Fergus Shanahan
Journal:  Gastroenterology       Date:  2007-07       Impact factor: 22.682

2.  Abdominal accommodation: a coordinated adaptation of the abdominal wall to its content.

Authors:  Albert Villoria; Fernando Azpiroz; Alfredo Soldevilla; Frederic Perez; Juan-Ramon Malagelada
Journal:  Am J Gastroenterol       Date:  2008-09-10       Impact factor: 10.864

3.  Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction.

Authors:  A Ait-Belgnaoui; W Han; F Lamine; H Eutamene; J Fioramonti; L Bueno; V Theodorou
Journal:  Gut       Date:  2006-02-28       Impact factor: 23.059

4.  Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome.

Authors:  Erja Malinen; Lotta Krogius-Kurikka; Anna Lyra; Janne Nikkilä; Anne Jääskeläinen; Teemu Rinttilä; Terttu Vilpponen-Salmela; Atte Johannes von Wright; Airi Palva
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

5.  The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat.

Authors:  D P McKernan; P Fitzgerald; T G Dinan; J F Cryan
Journal:  Neurogastroenterol Motil       Date:  2010-06-01       Impact factor: 3.598

6.  Bloating and distension in irritable bowel syndrome: the role of gastrointestinal transit.

Authors:  Anurag Agrawal; Lesley A Houghton; Brian Reilly; Julie Morris; Peter J Whorwell
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

7.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome.

Authors:  J Ritchie
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

8.  Abnormal colonic fermentation in irritable bowel syndrome.

Authors:  T S King; M Elia; J O Hunter
Journal:  Lancet       Date:  1998-10-10       Impact factor: 79.321

9.  Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.

Authors:  Samah O Noor; Karyn Ridgway; Louise Scovell; E Katherine Kemsley; Elizabeth K Lund; Crawford Jamieson; Ian T Johnson; Arjan Narbad
Journal:  BMC Gastroenterol       Date:  2010-11-12       Impact factor: 3.067

10.  Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.

Authors:  Lotta Krogius-Kurikka; Anna Lyra; Erja Malinen; Johannes Aarnikunnas; Jarno Tuimala; Lars Paulin; Harri Mäkivuokko; Kajsa Kajander; Airi Palva
Journal:  BMC Gastroenterol       Date:  2009-12-17       Impact factor: 3.067

View more
  3 in total

1.  Caecal pH is a biomarker of excessive colonic fermentation.

Authors:  Adam D Farmer; Sahar D Mohammed; George E Dukes; S Mark Scott; Anthony R Hobson
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 2.  Abdominal bloating: pathophysiology and treatment.

Authors:  A Young Seo; Nayoung Kim; Dong Hyun Oh
Journal:  J Neurogastroenterol Motil       Date:  2013-10-07       Impact factor: 4.924

3.  Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial.

Authors:  Giovanni Di Nardo; Salvatore Oliva; Federica Ferrari; Saverio Mallardo; Giovanni Barbara; Cesare Cremon; Marina Aloi; Salvatore Cucchiara
Journal:  BMC Gastroenterol       Date:  2013-09-24       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.